PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Jan-2025 Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders Angelini Ventures
08-Jan-2025 Cambridge Cognition highlights positive CANTAB® results in research by Bristol Myers Squib Cambridge Cognition
08-Jan-2025 Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics Antag Therapeutics
08-Jan-2025 Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders Angelini Ventures
08-Jan-2025 Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos
08-Jan-2025 Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Galapagos
08-Jan-2025 Medidata Signs Multi-Year Agreement with Bristol Myers Squibb to Extend Relationship and Continue Company’s Use of Platform Medidata
08-Jan-2025 Doubling of production capacity at the manufacturing site in Malmö PolyPeptide Group
07-Jan-2025 Evaluate Releases 2025 Preview for Pharma Market Evaluate
07-Jan-2025 Novartis gene therapy poised to expand SMA treatment landscape, says GlobalData GlobalData
07-Jan-2025 Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues Carterra
07-Jan-2025 Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil® Neuraxpharm
07-Jan-2025 4SC announces update relating to Resminostat’s (Kinselby) Marketing Authorisation Application 4SC
07-Jan-2025 QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening QUANTRO Therapeutics GmbH
07-Jan-2025 Immunic Highlights 2024 Accomplishments and Upcoming Milestones Immunic AG
07-Jan-2025 Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope Pentixapharm Holding AG
07-Jan-2025 Next-generation RNA company Inverna Therapeutics launched by Argobio and University of Southern Denmark Inverna Therapeutics
07-Jan-2025 Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division Kuros Biosciences AG
06-Jan-2025 Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group Santhera
06-Jan-2025 Gaelic Laboratories announces expansion enabling access to growing Middle East pharma market Gaelic Laboratories